---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-122240"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2025-12-16T23:59:59+00:00"
generated_at: "2026-05-16T13:06:54.840258+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD shareholders approve all proposals including share authorization increase to 640M

## Summary
- Four director nominees elected: Thompson, Collins, Naughton, Roberts; each received >5.1M for votes.
- Advisory say-on-pay approved: 5.16M for, 81.6K against, 8.3K abstain.
- Advisory vote on frequency: 1-year chosen (5.18M votes); board adopts annual advisory vote.
- Ratification of Berkowitz Pollack Brant as FY2025 auditor approved: 6.77M for, 42.2K against.
- Amendment to increase authorized common shares to 640M approved: 6.27M for, 548.9K against.

## SEC filing metadata
- accession: 0001213900-25-122240
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2025-12-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000121390025122240/0001213900-25-122240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000121390025122240/ea0269797-8k_therap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-122240
- JSON: https://secwatch.observer/filing/0001213900-25-122240.json
- Plain text: https://secwatch.observer/filing/0001213900-25-122240.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.